🧠 Why do some treatments stop working?
Part of the answer lies in the constant communication between tumour cells and their surroundings.
🔗 Learn more about CSIC’s role in CancerScan: https://t.co/Y8lnPnlOZW
#CancerInnovation#ResearchCollaboration#PrecisionMedicine
🎯Therapy response isn’t driven by cancer cells alone — it’s shaped by the tumour microenvironment and its ability to adapt.
#CancerScan identifies key TME contributors to guide patient-specific therapies.
📖 Read more: https://t.co/dyyP3TeZDP
#PersonalisedMedicine#Oncology
During his brief visit to the University of Bielefeld Igor Balaž (@neo_vivum) worked with the bioinformatics team on #CancerScan’s transcriptomics pipeline, mapping how organoid data feeds digital twins while balancing temporal resolution against cost constraints.
This insight from Ibane Abasolo (CSIC) captures why tumour microenvironment research is central to CancerScan’s mission.
Read more about the science behind this approach
👇https://t.co/Y8lnPnmmPu
#CancerScan#OncologyResearch#FutureOfMedicine
🔬 TME crosstalk shapes treatment response.
Cancer adapts through continuous dialogue with its surroundings — driving resistance, immune suppression & relapse.
At #CancerScan, we map the TME using multi-omics & digital pathology.
👉Read the full article: https://t.co/dyyP3TerOh
Tumour digital twins demand more than CPU-only computing. In #CancerScan, a heterogeneous GPU–FPGA infrastructure enables scalable, energy-efficient simulation of patient-specific tumours—bringing precision oncology closer to clinical reality. 🧬💻
#PrecisionMedicine#DigitalTwin
The EU is unlocking secure, interoperable health data through the EHDS & Cancer Imaging Initiative. #CancerScan supports this shift with AI-driven pathology and predictive analytics.
💡Learn more: https://t.co/9pCnAATaqm
🧠 Why is pancreatic cancer so difficult to treat?
A dense tumor microenvironment creates physical & biological barriers that limit drug penetration, boost cancer cell plasticity & fuel resistance.
Decoding this crosstalk is key — and exactly what #CancerScan tackles.
Precision oncology needs fast, energy-efficient tumour digital twin simulation. In #CancerScan, we combine GPUs and FPGAs to accelerate image analysis and enable clinically deployable digital twins for treatment optimisation.
🔗 Read the full article: https://t.co/R0jeSWwun5
Innovation matters only if it reaches everyone 🌍 The European Health Union + #EUCancerPlan promote equity & cross-border care. #CancerScan develops interoperable tools so all patients benefit from personalised treatment. 🏥🤝
🔍Explore further: https://t.co/1SHOcNDvZb
“CancerScan challenges us to rethink computing as part of the clinical workflow,” says Marco Santambrogio.
Politecnico di Milano is helping bring patient-specific tumour digital twins closer to clinical use with GPU–FPGA computing.
👉https://t.co/yydjqXiIK3
@polimi#computing
As 2025 ends, #CancerScan thanks all collaborators & partners for their support!🤝🧬
Excited to keep building patient-specific tumour digital twins & advancing precision oncology in the new year 🎄✨🚀
#DigitalPathology#CancerResearch#Innovation
Spotlight on @VHIR_ – Vall d’Hebron Research Institute 🧬🏥
VHIR leads organoid experiments, multi-omics analysis & slide digitalization in #CancerScan, linking patient care & research to validate new biomedical technologies.
👉 https://t.co/fReCaWKiWP
#CancerResearch#health
Meet Bielefeld University (UNIBI)🧬📘
UNIBI brings interdisciplinary expertise in AI, deep learning & multi-omics to #CancerScan, analysing tumour communication to support patient-specific digital twins.
🌐 https://t.co/HtIFgE6b9E
#DigitalHealth#EuropeanResearch#HorizonEU
Introducing Politecnico di Milano (@polimi) - who brings expertise in engineering, AI, and medical imaging to #CancerScan, leading image analysis & segmentation for patient-specific tumour digital twins.
Bridging research & real-world healthcare.🔧🔬
🚀 https://t.co/iRhEpsjD3U
Through @IQAC_CSIC in Barcelona, CSIC leads our patient-specific tumour digital twins project.
With strong expertise in chemical sciences, multi-omics, organoids & EU projects, they ensure rigorous data for precision cancer modelling.
👉 https://t.co/k6EPCjeTEL
#CancerScan
Meet MINDS & SPARKS – leading communication and dissemination in #CancerScan.
This independent non-profit organisation connects science, technology & society, ensuring project insights reach clinicians, researchers & citizens. 🌍🧬
Discover their work 👉 https://t.co/LCfCtVjrR5
Europe’s Beating Cancer Plan is transforming how we prevent, detect & treat cancer. Projects like #CancerScan support this vision by developing smarter, personalised diagnostic tools that bring innovation closer to every patient.
👉 https://t.co/dY6SIIEg7J
#EUCancerPlan#Health
Meet Neovivum Technologies, the mind behind #CancerScan - an AI-driven project decoding how tumors communicate.
Neovivum is developing advanced cognitive systems capable of generating tumor digital twins to advance precision oncology.
👉 https://t.co/iuy0Yh2FXu